Remove Bioinformatics Remove Gerontology Remove Trials
article thumbnail

Insilico Medicine gets $255 million to boost AI-powered R&D, announces a collaboration

Scienmag

Credit: Insilco June 22, 2021, New York / Hong Kong — Insilico Medicine, a global leader in end-to-end artificial intelligence for target discovery, small molecule chemistry, and clinical development, announced that it has closed a $255 million from biotechnology experts to progress Insilico Medicine’s current therapeutic programs into (..)

article thumbnail

Insilico announces a multi-target AI-powered drug discovery collaboration with Janssen

Scienmag

Credit: Insilico Tuesday, November 10, 2020 (9AM Beijing) – Insilico Medicine, a leader in deep generative reinforcement learning for target discovery, small molecule generation, and prediction of clinical trial outcomes, today announced that it entered into a multi-target drug discovery agreement with Janssen Pharmaceutica N.V.

Drugs 53